The carcinogenic and chronic toxicity potential of commercial hexane solvent was evaluated in F-344 rats and B 6 C 3 F 1 mice (50/sex/concentration/species) exposed by inhalation for 6 h/day, 5 days/week for 2 years. Target hexane vapor concentrations were 0, 900, 3000, and 9000 ppm. There were no significant differences in survivorship between control and hexane-exposed groups, and clinical observations were generally unremarkable. Small, but statistically significant decreases in body weight gain were seen in rats of both sexes in the mid-and high-exposure groups and in high-exposure female mice. The only noteworthy histopathological finding in rats was epithelial cell hyperplasia in the nasoturbinates and larynx of exposed groups. This response was judged to be indicative of upper respiratory tract tissue irritation. No significant differences in tumor incidence between control and hexaneexposed rats were found. In mice, uterine tissue from the highexposure females exhibited a significant decrease in the severity of cystic endometrial hyperplasia compared to controls. An increase in the combined incidence of hepatocellular adenomas and carcinomas was observed in high-exposure female mice. The incidence of liver tumors was not increased in the mid-or low-exposure female mice or in male mice exposed to hexane. An increased incidence of pituitary adenomas was observed in female, but not male mice. This finding was not believed to have been treatmentrelated because the incidence in the control group was unusually low, and the incidence in exposed groups was not dose-related and was within the historical control range. No other neoplastic changes judged to be treatment-related were observed in tissues from male or female mice. In conclusion, chronic exposure to commercial hexane solvent at concentrations up to 9000 ppm was not carcinogenic to F-344 rats or to male B 6 C 3 F 1 mice, but did result in an increased incidence of liver tumors in female mice.
Commercial hexane is a petroleum-derived solvent widely used in a number of industrial applications, including the extraction of oils from a variety of edible seeds, in the formulation of adhesives and solvents, and as a reaction diluent in the manufacture of polyolefins. It is a mixture of six-carbon isomers comprised primarily of n-hexane, 3-methylpentane, methylcyclopentane, and 2-methylpentane (see Table 1 ). An extensive industry-sponsored animal testing program has been carried out on commercial hexane to investigate a wide range of health effects endpoints. This program included studies to assess genotoxicity, pharmacokinetics, developmental toxicity, reproductive toxicity, neurotoxicity, subchronic toxicity, and carcinogenicity. The testing was conducted pursuant to provisions issued by the U.S. Environmental Protection Agency under Section 4 of the Toxic Substances Control Act (EPA, 1988a,b) . Results from many of these studies have been published (Daughtrey et al., 1994a,b) or released in abstract form Keenan et al., 1991; Kirwin et al., 1991; Soiefer et al., 1991) .
While considerable toxicity and metabolism data existed on the n-hexane isomer (for review, see Arlien-Soborg, 1992) prior to the industry program, far less data were available on the other six-carbon isomers present in the commercial hexane mixture. Results from the genotoxicity test battery indicated that commercial hexane was not mutagenic or clastogenic in a series of in vitro and in vivo assays (Daughtrey et al., 1994a; Kirwin et al., 1991) . Although the available data were not suggestive of genotoxic or carcinogenic potential, neither the commercial hexane mixture itself nor its component isomers had been previously tested by inhalation in a rodent carcinogenicity bioassay. The data reported in the present paper provide the results of the carcinogenicity study on commercial hexane solvent, which was conducted with Fischer 344 rats and B 6 C 3 F 1 mice.
tories, Raleigh, NC) and B 6 C 3 F 1 mice (Charles River Laboratories, Portage, MI) were obtained and acclimated for approximately 4 weeks. At the initiation of exposures, rats were 8 weeks-of-age and weighed from 120 to 181 g (males) or 111 to 126 g (females). Mice were also approximately 8 weeks-of-age and weighed from 21 to 26 g (males) or 17-22 g (females). The animals were individually housed in suspended stainless steel wire-mesh cages and provided with food and water ad libitum, except during the 6-h inhalation exposures. Rooms were maintained on a 12-h light/dark cycle and at a temperature and humidity of 22 Ϯ 1°C and 53 Ϯ 14%, respectively. Animals were randomly assigned to experimental groups based on weight. All animals were ranked by body weight for each species and sex. The central 200 animals were selected. The lightest four animals were randomly assigned to the four groups (one to each), then the next 4 lightest, and so on.
Experimental design. The potential carcinogenicity of hexane was investigated by exposing Fischer 344 rats and B 6 C 3 F 1 mice to hexane vapors 6 h/day, 5 days/week for 2 years. Target concentrations were 0 (control), 900, 3000, or 9000 ppm vapor. In this study, detailed physical examinations were conducted pretest, and weekly thereafter. Body weight measurements were recorded three times pretest, weekly through week 13, monthly thereafter, and just prior to sacrifice. Ophthalmoscopic examinations were performed on all animals pretest and prior to sacrifice. Blood samples were obtained from all survivors at months 12 and 18, via a tail nick, and at termination, via venipuncture of the orbital sinus. These samples were analyzed for differential leukocyte counts and erythrocyte morphology (Schermer, 1967) .
Any animals found dead or sacrificed prior to study termination were necropsied. After 2 years of exposure, all surviving rats and mice were sacrificed. Complete macroscopic postmortem examinations and microscopic examination of selected tissues were conducted. Following routine processing in neutral buffered 10% formalin, tissues were embedded in paraffin and stained with hematoxylin-eosin. Sections of the following tissues were examined histologically in the control and high-exposure-level groups, as well as in all animals that died prior to study termination: adrenal glands, aorta, bone and bone marrow (femur and sternum), brain (medulla/pons, cerebrum and cerebellum), esophagus, exorbital lacrimal gland, eyes, gall bladder (mice only), gonads (ovaries or testes with epididymides), heart, intestine (cecum, colon, duodenum, ileum, jejunum, rectum), kidneys, larynx, lymph nodes (mesenteric and peribronchial), liver, lungs, nasoturbinates, nerve (sciatic and optic), pancreas, pituitary, prostate, salivary gland (submandibular), skin, spinal cord, spleen, stomach, thymic region, thyroid/parathyroid, trachea, urinary bladder, uterus (horns and cervix), tissue masses, and macroscopic lesions. The nasoturbinates were examined based upon the procedure of Young (1981) . Four nasoturbinate sections per animal were examined. The first section included the area between the upper incisor tooth and the incisive papilla. The second section included the area between the incisive papilla and the first palatal ridge. The third section included the area between the second palatal ridge and the first upper molar tooth. The fourth section included the area between the first upper molar tooth and the nasopharynx. The larynx was examined based upon the procedure of Sagartz et al. (1992) . Selected additional tissues from the lowand mid-exposure groups of rats and mice were also examined. These were as follows: in mice, any tissue masses, lungs and livers from both sexes, and pituitaries from females; in rats, any tissue masses, lungs, and nasoturbinates.
For those microscopic findings that were graded with respect to severity on a scale of 0 to 4, the severity scores were based upon the approximate percentage of tissue involved. Those severities were: none (0%), minimal (above 0% to under 2%), slight (from 2 to under 10%), moderate (from 10 to under 30%), and severe (30% and over).
This study was conducted in accordance with the requirements and recommendations of the Animal Welfare Act (PL 89-544 as amended by PL 91-579 and PL 94-279). Bio/dynamics, Inc. was accredited by the American Association for Accreditation of Laboratory Animal Care (AAALAC).
Exposures. The whole-body inhalation exposures were conducted in identical 10,000 liter chambers, with rats and mice being exposed concurrently. The stainless steel and glass chambers (Hartford, Aberdeen, MD) had pyramidal tops and bottoms. Chamber airflow entered tangentially through a turret into the top of the chambers to facilitate air mixing within the chamber. The chambers were operated dynamically at flow rates (2000 -2130 liters/minute) that provided one complete air change approximately every 5 min, with 99% equilibrium times of 22-23 min. All chambers were operated at slight negative pressure (Ϫ0.5 cm H 2 O) relative to the surrounding area. Chamber airflow, temperature, and relative humidity were recorded every 30 min during the exposures. The animals were individually housed in open mesh cages during exposure. Each animalЈs location in the chamber was rotated on a weekly basis throughout the study. After exiting the chamber, the hexane laden atmospheres went through coarse and HEPA filters to remove any particulate, and then through an incinerator (MOCO, Romulus, MI), prior to exhausting to the atmosphere. As a backup in the event of incinerator failure (never occurred), a 55-gallon charcoal drum could be switched into the exhaust pipe of each chamber.
The hexane-laden atmospheres were generated for the whole-body exposures using counter-current, glass volatilization chambers (Crown Glass, Somerville, NJ). The volatilization chamber consisted of 2 concentric glass tubes sealed at the ends. The outer tube had ports for the delivery of the test material and nitrogen and the exhaust of the vapor-laden atmospheres. The inner glass tube was equipped with a glass coil spiraling down around the outside of the tube and an internal heating element. Hexane was pumped onto the top of the glass coil where it flowed down and around the heated tube. Heated nitrogen was introduced at the bottom of the volatilization unit to flow upwards, counter to the flow of the hexane, to maximize volatilization. The vapors were generated under nitrogen to get the vapor laden atmospheres near or below the lower-explosive-limit prior to mixing with air. The output of the volatilization chamber was then connected to the entry turret of the exposure chamber where it mixed with air prior to entrance into the animal compartment of the chamber. Two counter-current volatilization chambers were used in parallel for the 3000 ppm exposure chamber, and three in-parallel units were used to achieve 9000 ppm.
In order to safely handle and generate atmospheres of this flammable mixture, several precautionary procedures were adopted. The 55-gallon drums were stored within a solvent shed detached from the main building. The hexane was dispensed as needed, for use in this study, into 5-gallon safety containers. The drum and container were connected to each other with a grounding wire during this transfer. A nitrogen head-space was maintained in all drums and containers. To generate the exposure atmospheres, the hexane was evaporated and diluted, using heated nitrogen. The temperature of the counter-current evaporation unit was continuously monitored with a temperature monitor equipped with an audible alarm for any temperature excursions. The highexposure level for this study was set for safety reasons at 9000 ppm (parts- a Composition as determined by gas chromatographic analysis.
per-million) of hexane vapor in air, or approximately 75% of the LEL (lower explosive limit).
Exposure atmosphere analyses. The exposure atmospheres were measured hourly during each exposure using an infrared spectrophotometer (Wilks, MIRAN ® , Foxboro, MA). The exposure levels were determined by comparison of the measured absorbance to a calibrated response curve, constructed using the same instrument settings (wavelength ϭ 3.68 m). A 5-point calibration curve was constructed pre-study and a 3-point calibration check performed daily using a closed-loop calibration system.
The stability and purity of the test material was documented by gas chromatographic analysis. Samples of the neat material as well as vapor samples from the breathing zone in each chamber were collected monthly over the course of the study. The exposure chamber samples were collected in two charcoal tubes (SKC, Inc.) in tandem. The charcoal tube samples were desorbed with carbon disulfide. Samples were injected (2 l) and analyzed on a gas chromatograph (Hewlett Packard 5890 Series II) equipped with an automatic sampler (HP7671), a flame-ionization-detector, a DB-1701 column (30 m ϫ 0.531 mm id) with a 1.5 m film thickness, and helium carrier gas. The inlet temperature was 150°C. and the detector temperature was 300°C. The column followed a ramped temperature profile with the initial temperature at 30°C for 2 min followed by a 1°C/min ramp to 40°C. Each sample was analyzed in duplicate, and a standard was injected after every fourth injection.
Before any animal exposures were conducted, chamber samples were collected to demonstrate hexane homogeneity throughout the exposure chamber. Samples were collected from both left and right sides, front and back, top and bottom, and from the normal sampling portal, and these samples indicated that the concentrations within the chamber were homogeneous. In addition, in measuring for the presence of any hexane as an aerosol, particle size distribution measurements were made monthly in all chambers, including control, using a factory-calibrated TSI Aerodynamic Particle Sizer.
Statistical analyses. In-life body weight and terminal body weight data were evaluated by the appropriate one-way analysis of variance (ANOVA), followed by a multiple comparison procedure if needed. BartlettЈs test (Snedecor and Cochran, 1989) was performed to determine if groups have equal variance. If the variances were equal, parametric procedures were used; if not, nonparametric procedures were used. The parametric procedures were the standard one-way ANOVA, using the F distribution to assess significance (Snedecor and Cochran, 1989) . If significant differences among the means were indicated, DunnettЈs test (Dunnett, 1964) was used to determine which means were significantly different from the control. If a nonparametric procedure for testing equality of means was needed, the Kruskal Wallis test (Hollander and Wolfe, 1973) was used, and if differences were indicated, DunnЈs summed rank test (Hollander and Wolfe, 1973) was used to determine which treatments differ from control. A statistical test for trend in the dose levels was also performed. In the parametric case, standard regression techniques, with a test for trend and lack of fit, was used (Snedecor and Cochran, 1989) . In the nonparametric case, JonckheereЈs test for monotonic trend was used (Hollander and Wolfe, 1973) . The test for equal variance (BartlettЈs) was conducted at the 1% two-sided risk level. All other statistical tests were conducted at the 5% and 1%, two-sided risk levels.
Statistical analysis of tumor incidence data was performed using contingency tables. An exact probability Pearson chi-square analysis (Agresti, 1990) was performed to determine if the proportion of incidence differed between the groups tested. Each exposure group was compared to the control group using a one-sided 2 ϫ 2 Fisher Exact test (Bradley, 1968) . Trends in the dose groups were tested using the exact probability, one-sided Cochran-Armitage test (Mehta, et al, 1991) .
Survival data was analyzed for each sex separately by the series of analyses included in the N.C.I. (National Cancer Institute) analysis package for time to death accounting for scheduled and accidental deaths (Thomas et al., 1977 ). An assessment of mortality was made by the Kaplan Meier method. Severity scores were analyzed by a cumulative-odds, logistic-regression model (Armstrong and Sloan, 1989) , also known as a proportional-odds, logistic-regression model (McCullagh and Nelder, 1989) . The model considers the incidence and severity of the responses and compares the treatment groups to the control group, based on a two-sided hypothesis.
RESULTS

Chamber Monitoring
Analyses of hexane from the storage drums and exposure atmospheres indicated that the composition of the test atmospheres in the exposure chambers was the same as the neat material. In addition, the hexane was stable over the duration of the study, and its composition met the criteria (40 -55% nhexane and greater than 10% methylcyclopentane), as set forth in the test rule requiring this study (EPA, 1988b) .
The actual mean hexane-exposure levels during the 2-year study were: 0, 900 Ϯ 38, 3000 Ϯ 116, and 9016 Ϯ 445 ppm. These values show very good agreement between target and actual exposure levels. Particle-size distribution measurements indicated that there was no significant aerosol of hexane present in any chamber. Chamber environmental conditions averaged 22°C, 50% relative humidity, and over 19% oxygen.
Clinical Observations
Clinical observations in both rats and mice were generally unremarkable. An increased incidence of lacrimation was noted in male rats of the mid-(3000 ppm) and high (9000 ppm) exposure groups. However, in female rats and in mice of both sexes the incidence of lacrimation appeared to be equally distributed among groups, including controls. Ophthalmoscopic examinations did not reveal the existence of any hexane-related ocular effects.
Mean Body-Weight Gain
Small, but statistically significant, decreases in body-weight gain were seen in rats of the 3000-and 9000-ppm-exposure groups during the course of the study (Fig. 1) . At study termination, the mean body weights of high-exposure male and female rats were 7 and 11% lower than control values, respectively. In the mid-exposure group of rats, terminal body weights of males and females were 5 and 3% lower than controls, respectively. Group-mean body weights of the lowexposure rats were not statistically different from controls at the end of the study.
For male mice, significant differences in mean body weight were not observed among the groups (Fig. 2a) . For highexposure females, group-mean body weights were significantly lower than control values after week 29, and by week 53 body weight was 14% lower than control (Fig. 2b) . At study termination (week 103), the body weight difference was only 3%. Body weight gain in the mid-and low-exposure female mice was similar to that seen in controls.
Survival
There were no significant differences in survivorship between control and commercial-hexane-exposed groups of rats and mice (Figs. 3 and 4) . At the end of 24 months, survival in male rats was 67, 62, 64, and 67% for the control, low-, mid-, and high-exposure groups, respectively. Survival at 24 months in female rats was 76, 80, 72, and 80% for the control, low-, mid-, and high-exposure groups, respectively.
For mice, survival in males at 24 months was 85, 82, 90, and 84% for the control, low-, mid-, and high-exposure groups, respectively. For female mice, survival at 24 months was 80, 79, 71, and 78% for the control, low-, mid-, and high-exposure groups, respectively.
Clinical Laboratory Evaluation
There were no indications of hexane-related effects on differential leukocyte count or erythrocyte morphology in either rats or mice (data not shown).
Pathological Evaluation
Rats. Hexane-related macroscopic abnormalities among rats were not observed at necropsy, during the study or at the 24-month study termination. Treatment-associated microscopic findings were limited to hyperplasia and inflammation of the epithelium in the nasal turbinates and larynges of both sexes (Table 2 ). Specific findings in the nasoturbinates consisted of epithelial and goblet-cell hyperplasia, increases in intracytoplasmic eosinophilic material, and chronic inflammation. These findings were considered to be an expected response to irritation of the upper respiratory tract. The exact nature of the intracytoplasmic eosinophilic material (presumed to be secretory) and the reason for its increase following exposure to irritants are not known. The nasoturbinate findings were observed in all exposure groups, and a clear NOEL was not identified. However, the incidence and severity was greatest in the mid-and high-exposure groups.
The principal finding in the larynx was hyperplasia/metapla-
FIG. 1. (a)
Mean body weights of male rats exposed to commercial hexane; (b) mean body weights of female rats exposed to commercial hexane.
FIG. 2. (a)
Mean body weights of male mice exposed to commercial hexane; (b) mean body weights of female mice exposed to commercial hexane.
sia of the columnar epithelium. In general, this finding was not statistically significant and was only observed in a small number of animals, but the incidence was greatest among animals of the high (9000 ppm)-exposure group. The finding was considered to be a localized response indicative of irritation.
Other microscopic findings in the array of tissues examined occurred with comparable incidence and severity in control and hexane-exposed groups. No statistically significant differences in tumor incidence between control and exposed animals were observed.
Mice. A statistically significant increase in hepatocellular neoplasms was found among females in the high-exposure group (Table 3 ). The incidence of adenomas or carcinomas was not significant for the overall comparison test, the trend test, or group pairwise comparisons. When benign and malignant liver tumors were combined, there was a statistically significant trend and a significant pairwise comparison between the control and high-exposure female groups (14% versus 32% incidence for the control and high-exposure groups, respectively).
In contrast to females, an increase in the incidence of liver tumors was not observed among male mice (35, 32, 34, and 26% combined incidence in control, low-, mid-, and highexposure groups, respectively). No other treatment-related liver lesions were observed in either males or females.
An increased incidence of pituitary adenomas was also observed in female, but not male, mice (Table 4) . It should be noted, however, that this response was not dose related (i.e., the incidence was similar among all three treatment groups). Moreover, the overall incidence of these changes is within the mouse strainЈs historical control range. Control data for untreated B 6 C 3 F 1 mice published by NTP in 1985 (Haseman, et al. 1985) indicates a range of 0 to 30% and a mean of 8.6% for adenomas of the pituitary gland. In the current study, this compares to an incidence of 12, 14, and 10% for females of the low-, mid-, and high-exposure groups. The apparent increase is believed to have been due to an unusually low incidence among controls of this particular study (0%) and not attributable to hexane exposure per se. It should also be noted that the in-life portion of the current study was conducted from 1990 through 1992. More recent control data published by NTP (Haseman et al., 1998) actually strengthen the interpretation that the non-dose-related increase in pituitary tumors in female mice is not hexane related. The current chamber-control pituitary tumor incidence in B 6 C 3 F 1 mice, as reported by Haseman et al. (1998) , averages 19.2% with a range of 2-44%. Thus, pituitary tumor responses in the present study are actually somewhat lower than the recent control values reported by NTP.
Uterine tissue from high-exposure females had a statistically significant decrease in the severity of cystic endometrial hyperplasia compared to controls (Table 5 ). This finding correlated with a decrease in uterine cysts observed at necropsy in high-exposure females compared to controls (data not shown). An increase in cystic endometrial hyperplasia of the uterus is a normal age-related change in B 6 C 3 F 1 mice and is thought to be related to a change in hormonal balance with aging.
No other treatment-related neoplastic or non-neoplastic changes were observed in tissues from male or female mice of this study.
DISCUSSION
Chronic exposure of rats and mice to commercial hexane solvent at concentrations up to 9000 ppm did not adversely affect survival or produce signs of overt clinical toxicity. Overall survival of both rats and mice was relatively high in this study, averaging approximately 70 to 80% at the end of 2 years. In rats, the only histopathological finding of note was epithelial cell hyperplasia in the nasoturbinal tissues and larynges. This finding is indicative of local tissue irritation. In none of these animals was there evidence of progression to dysplasia or neoplastic growths. Given that the concentrations used in this study were very high (i.e., the high dose was approximately 75% of the lower explosive limit), and that the rat is an obligate nose-breather, this response is not surprising. At high concentrations, most hydrocarbon solvents are irritating to the upper respiratory tract (Cavender, 1994) . In mice, an increase in the incidence of combined benign and malignant liver tumors was observed in high-exposure group females. (The incidences of either tumor type, alone, were not statistically different from control.) The incidence of liver tumors was not increased in the mid-or low-exposure group female mice or in male mice at any exposure level. It is noteworthy that, in the present study, the incidence of liver tumors in the high-exposure group females (32%) was similar to the incidence observed in concurrent control male mice (35%). Based on historical control data, the spontaneous rate of hepatocellular tumors in B 6 C 3 F 1 mice is known to be significantly higher in males than females; a review of data published by the National Toxicology Program in 1985 indicated a mean incidence of 30% in untreated B 6 C 3 F 1 males versus 8% in untreated females (Haseman et al., 1985; Maronpot et al., 1987) . More recent chamber control data from NTP (Haseman et al., 1998) indicates an increase in the incidence of liver tumors among B6C3F1 mice, with a mean rate in males of 42.1% (range 11-70%) and a mean rate in females of 25.2% (range 3-54%). The current study was conducted during 1990 through 1992, approximately midway between the two published NTP studies. The basis for this sex-related difference in liver tumors has been the subject of considerable research, and it appears that the effects of estrogens and androgens play an important role. Ovariectomy and the administration of testosterone have been shown to enhance spontaneous hepatocellular tumor incidence in females, whereas castration and estrogen administration reduce the incidence in males (Kemp et al., 1989; Kemp and Drinkwater, 1990; Maronpot et al., 1987) .
Liver-tumor induction in mice is one of the most common findings in cancer bioassays. Controversy regarding the validity of using mouse liver-tumor development in human risk assessment stems from the high incidence and variability of liver tumors in both control and chemically-exposed mice. Resolution of this controversy will ultimately require better understanding of the underlying pathogenic mechanisms by which these tumors arise.
Chronic exposure of B 6 C 3 F 1 mice to wholly vaporized unleaded gasoline has also been shown to increase the incidence of hepatocellular tumors in female mice (MacFarland et al., 1984) . Since hexanes are a component of gasoline, the gasoline results were judged to be of relevance for the present study. In the gasoline bioassay, rats and mice of both sexes were exposed by inhalation 6h/day, 5 days/wk to 67, 292, and 2056 ppm of gasoline vapor. An increased incidence of hepatocellular tumors was observed in the high-exposure females, but not in the mid-and low-exposure females or in male mice. Gasoline-induced liver tumors were also not observed in either sex of F-344 rats. In re-examining the gasoline study, MacGregor et al., (1993) reported a marked reduction in the severity of cystic hyperplasia in uteri of mice exposed to the high concentration compared to controls. Moreover, uteri from 35% of high-dose mice were atrophic, whereas this finding was absent in control mice. Cystic endometrial hyperplasia is a common spontaneous condition in mice, and in many strains nearly every female older than 18 months will have it to some degree (MacGregor, 1993) . It is generally believed to result from changes in the relative levels of estrogen and progesterone. MacGregor (1993) also noted that the uterine changes in gasoline-exposed mice were consistent with an altered hormonal influence on the uterus and that the uterine changes and increased liver tumors in the high-dose mice might be related. To pursue this question, other researchers have hypothesized that high concentrations of gasoline might be antiestrogenic in mice and that liver tumor promotion by gasoline might be secondary to antiestrogenic actions (Standeven et al., 1994a) . This hypothesis was based, in part, on the fact that estrogens are necessary for uterine growth, and antagonism of estrogenic actions might induce the forementioned uterine changes. Subsequent research has suggested that the uterine effects caused by chronic exposure of mice to gasoline are probably not due to direct antiestrogenic effects, but rather may only be due to indirect "antiestrogenic" consequences (Standeven et al., 1994a,b) . In the present study, uterine tissue from the highdose hexane-exposed females also revealed a significant decrease in the severity of cystic endometrial hyperplasia compared to controls. It is not known whether or not this finding is related to the increased incidence of liver tumors observed in this same group of animals.
Finally, it should also be noted that in the present study on commercial hexane solvent (containing 52% n-hexane), no neurotoxic effects characteristic of n-hexane were observed. Moreover, in a separate 13-week subchronic inhalation study of commercial hexane, using the same exposure paradigm (i.e., 900, 3000, and 9000 ppm for 6 h/day, 5 days/week), a detailed neurobehavioral/neuropathological evaluation revealed no nhexane-induced neuropathy . The lack of neurotoxic effects in these studies of commercial hexane (containing 52% n-hexane) is consistent with previously published laboratory findings. In rodents, nearly continuous (i.e., 22 h/day) subchronic inhalation exposure to n-hexane is required to produce neuropathy at concentrations less than 10,000 ppm (Cavender et al., 1984; Dunnick et al., 1989) .
In conclusion, chronic exposure to commercial hexane solvent at concentrations up to 9000 ppm was not carcinogenic in Fischer 344 rats. Histological evidence of mucosal irritation was observed in the nasal turbinates of all hexaneexposed rats; the NOAEL for this effect was not identified but is less than 900 ppm. In B 6 C 3 F 1 mice an increased incidence of hepatocellular neoplasms (combined adenomas and carcinomas) was observed in females of the highexposure group (9000 ppm). No carcinogenic effects were observed in mid-or low-exposure group females or in hexane-exposed male mice. The relevance for humans of these hexane-induced mouse liver tumors is questionable. Better understanding of the underlying mechanism by which they arise should help resolve the uncertainty regarding the utility of these findings in human health risk assessment.
